Lucid Group Company
Lucid aims to develop a unique 3 in one diagnostic device. The device would help intuitive, fast and economic measure biophysiological markers (pressure, sensation and muscle contractility вАУ via EMG), enabling more precise diagnosis of the functional deficits in faecal incontinence at primary care.
Investors
Connections from
Headquarters:
Manchester, Manchester, United Kingdom
Total Funding:
£719 947
Founded Date:
2002
Employee Number:
11-50
Last Funding Type:
Grant
Investors Number:
4
Last Funding Date:
02-01-2015
Funding Status:
Private
Estimated Revenue:
< £780 000
Industry:
P4 medicine